By Notice dated July 31, 2007 and published in the Federal Register on August 9, 2007, (72 FR 4485944860), Aptuit (Allendale), Inc., 75 Commerce Drive, Allendale, New Jersey 07401, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Noroxymorphone (9668), a basic class of controlled substance listed in schedule II.

The company plans to import the basic class of controlled substance for clinical trials and research.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Aptuit (Allendale), Inc. to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Aptuit (Allendale), Inc. to ensure that the company's registration is consistent with the public interest. Th ]]> http://thefederalregister.com/d.p/2007-12-11-E7-23978 Tue, Dec 11 2007 11:00:00 GMT